Literature DB >> 24417450

Fitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β' subunit of RNA polymerase.

Taeksun Song1, Yumi Park, Isdore Chola Shamputa, Sunghwa Seo, Sun Young Lee, Han-Seung Jeon, Hongjo Choi, Myungsun Lee, Richard J Glynne, S Whitney Barnes, John R Walker, Serge Batalov, Karina Yusim, Shihai Feng, Chang-Shung Tung, James Theiler, Laura E Via, Helena I M Boshoff, Katsuhiko S Murakami, Bette Korber, Clifton E Barry, Sang-Nae Cho.   

Abstract

Rifampicin resistance, a defining attribute of multidrug-resistant tuberculosis, is conferred by mutations in the β subunit of RNA polymerase. Sequencing of rifampicin-resistant (RIF-R) clinical isolates of Mycobacterium tuberculosis revealed, in addition to RIF-R mutations, enrichment of potential compensatory mutations around the double-psi β-barrel domain of the β' subunit comprising the catalytic site and the exit tunnel for newly synthesized RNA. Sequential introduction of the resistance allele followed by the compensatory allele in isogenic Mycobacterium smegmatis showed that these mutations respectively caused and compensated a starvation enhanced growth defect by altering RNA polymerase activity. While specific combinations of resistance and compensatory alleles converged in divergent lineages, other combinations recurred among related isolates suggesting transmission of compensated RIF-R strains. These findings suggest nutrient poor growth conditions impose larger selective pressure on RIF-R organisms that results in the selection of compensatory mutations in a domain involved in catalysis and starvation control of RNA polymerase transcription.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24417450      PMCID: PMC3951610          DOI: 10.1111/mmi.12520

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  42 in total

1.  Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance.

Authors:  J Björkman; I Nagaev; O G Berg; D Hughes; D I Andersson
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

2.  Transcriptional analysis of inducible acetamidase gene of Mycobacterium smegmatis.

Authors:  S Narayanan; S Selvakumar; R Aarati; S K Vasan; P R Narayanan
Journal:  FEMS Microbiol Lett       Date:  2000-11-15       Impact factor: 2.742

3.  A structural model of transcription elongation.

Authors:  N Korzheva; A Mustaev; M Kozlov; A Malhotra; V Nikiforov; A Goldfarb; S A Darst
Journal:  Science       Date:  2000-07-28       Impact factor: 47.728

4.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

5.  Structural mechanism for rifampicin inhibition of bacterial rna polymerase.

Authors:  E A Campbell; N Korzheva; A Mustaev; K Murakami; S Nair; A Goldfarb; S A Darst
Journal:  Cell       Date:  2001-03-23       Impact factor: 41.582

Review 6.  Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution.

Authors:  Sophie Maisnier-Patin; Dan I Andersson
Journal:  Res Microbiol       Date:  2004-06       Impact factor: 3.992

7.  The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice.

Authors:  John L Dahl; Carl N Kraus; Helena I M Boshoff; Bernard Doan; Korrie Foley; David Avarbock; Gilla Kaplan; Valerie Mizrahi; Harvey Rubin; Clifton E Barry
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-01       Impact factor: 11.205

8.  Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains.

Authors:  R D Fleischmann; D Alland; J A Eisen; L Carpenter; O White; J Peterson; R DeBoy; R Dodson; M Gwinn; D Haft; E Hickey; J F Kolonay; W C Nelson; L A Umayam; M Ermolaeva; S L Salzberg; A Delcher; T Utterback; J Weidman; H Khouri; J Gill; A Mikula; W Bishai; W R Jacobs; J C Venter; C M Fraser
Journal:  J Bacteriol       Date:  2002-10       Impact factor: 3.490

9.  Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis.

Authors:  Deneke H Mariam; Yohannes Mengistu; Sven E Hoffner; Dan I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

10.  Evolutionary connection between the catalytic subunits of DNA-dependent RNA polymerases and eukaryotic RNA-dependent RNA polymerases and the origin of RNA polymerases.

Authors:  Lakshminarayan M Iyer; Eugene V Koonin; L Aravind
Journal:  BMC Struct Biol       Date:  2003-01-28
View more
  38 in total

1.  Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done.

Authors:  Marco Schito; Markus Maeurer; Peter Kim; Debra Hanna; Alimuddin Zumla
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

2.  Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis.

Authors:  Grant Theron; Jason Limberis; Rouxjeane Venter; Liezel Smith; Elize Pietersen; Aliasgar Esmail; Greg Calligaro; Julian Te Riele; Marianna de Kock; Paul van Helden; Tawanda Gumbo; Taane G Clark; Kevin Fennelly; Robin Warren; Keertan Dheda
Journal:  Nat Med       Date:  2020-06-29       Impact factor: 53.440

3.  Characterization of Mutations Conferring Resistance to Rifampin in Mycobacterium tuberculosis Clinical Strains.

Authors:  Tomasz Jagielski; Zofia Bakuła; Anna Brzostek; Alina Minias; Radosław Stachowiak; Joanna Kalita; Agnieszka Napiórkowska; Ewa Augustynowicz-Kopeć; Anna Żaczek; Edita Vasiliauskiene; Jacek Bielecki; Jarosław Dziadek
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

4.  In vitro and in vivo fitness costs associated with Mycobacterium tuberculosis RpoB mutation H526D.

Authors:  Dalin Rifat; Victoria L Campodónico; Jing Tao; James A Miller; Alpaslan Alp; Yufeng Yao; Petros C Karakousis
Journal:  Future Microbiol       Date:  2017-03-27       Impact factor: 3.165

5.  De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.

Authors:  Jees Sebastian; Sharmada Swaminath; Rashmi Ravindran Nair; Kishor Jakkala; Atul Pradhan; Parthasarathi Ajitkumar
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 6.  Ecology and evolution of Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux
Journal:  Nat Rev Microbiol       Date:  2018-02-19       Impact factor: 60.633

7.  Structural basis for rifamycin resistance of bacterial RNA polymerase by the three most clinically important RpoB mutations found in Mycobacterium tuberculosis.

Authors:  Vadim Molodtsov; Nathan T Scharf; Maxwell A Stefan; George A Garcia; Katsuhiko S Murakami
Journal:  Mol Microbiol       Date:  2017-01-10       Impact factor: 3.501

8.  Investigation of ( S)-(-)-Acidomycin: A Selective Antimycobacterial Natural Product That Inhibits Biotin Synthase.

Authors:  Matthew R Bockman; Curtis A Engelhart; Julia D Cramer; Michael D Howe; Neeraj K Mishra; Matthew Zimmerman; Peter Larson; Nadine Alvarez-Cabrera; Sae Woong Park; Helena I M Boshoff; James M Bean; Victor G Young; David M Ferguson; Veronique Dartois; Joseph T Jarrett; Dirk Schnappinger; Courtney C Aldrich
Journal:  ACS Infect Dis       Date:  2019-02-04       Impact factor: 5.084

9.  Source of the Fitness Defect in Rifamycin-Resistant Mycobacterium tuberculosis RNA Polymerase and the Mechanism of Compensation by Mutations in the β' Subunit.

Authors:  Maxwell A Stefan; Fatima S Ugur; George A Garcia
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

Review 10.  The potential impact of coinfection on antimicrobial chemotherapy and drug resistance.

Authors:  Ruthie B Birger; Roger D Kouyos; C Jessica E Metcalf; Ted Cohen; Emily C Griffiths; Silvie Huijben; Michael J Mina; Victoriya Volkova; Bryan Grenfell
Journal:  Trends Microbiol       Date:  2015-05-29       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.